UBS AM’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $82.9K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $307K | Sell |
|
|||||
|
2023
Q2 | $566K | Hold |
|
|||||
|
2023
Q1 | $566K | Buy |
|
|||||
|
2022
Q4 | $445K | Hold |
|
|||||
|
2022
Q3 | $594K | Hold |
|
|||||
|
2022
Q2 | $656K | Hold |
|
|||||
|
2022
Q1 | $680K | Hold |
|
|||||
|
2021
Q4 | $944K | Hold |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $620K | Sell |
|
|||||
|
2020
Q4 | $629K | Hold |
|
|||||
|
2020
Q3 | $462K | Hold |
|
|||||
|
2020
Q2 | $547K | Buy |
|
|||||
|
2020
Q1 | $467K | Buy |
|
|||||
|
2019
Q4 | $652K | Sell |
|
|||||
|
2019
Q3 | $593K | Buy |
|
|||||
|
2019
Q2 | $484K | Buy |
|
|||||
|
2019
Q1 | $334K | Buy |
|
|||||
|
2018
Q4 | $351K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $271K | Hold |
|
|||||
|
2016
Q2 | $182K | Buy |
|
|||||
|
2016
Q1 | $123K | Sell |
|
|||||
|
2015
Q4 | $283K | Sell |
|
|||||
|
2015
Q3 | $358K | Buy |
|
|||||
|
2015
Q2 | $379K | Buy |
|
|||||
|
2015
Q1 | $265K | Buy |
|
|||||
|
2014
Q4 | $394K | Buy |
|
|||||
|
2014
Q3 | $124K | Hold |
|
|||||
|
2014
Q2 | $193K | Buy |
|